Your session is about to expire
← Back to Search
Primary Care Linkage for Addiction Treatment (Linkage Trial)
N/A
Waitlist Available
Led By Constance M Weisner, DrPH, LCSW
Research Sponsored by Kaiser Permanente
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Research participants will be adult patients at the Kaiser Permanente San Francisco Chemical Dependency Recovery Program, who have completed 2 weeks of treatment.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 and 24 months post baseline
Awards & highlights
Linkage Trial Summary
This trial improves drug abuse treatment by connecting specialty drug treatment and primary health care.
Who is the study for?
This trial is for adults at the Kaiser Permanente San Francisco Chemical Dependency Recovery Program who have finished at least 2 weeks of treatment for substance use disorders, including addiction and alcoholism. Those with dementia, mental retardation, or current psychosis or suicidal tendencies cannot participate.Check my eligibility
What is being tested?
The study tests a 'linkage patient activation intervention' designed to improve connections between specialty drug treatment and primary health care as part of enhancing overall drug abuse treatment.See study design
What are the potential side effects?
Since this trial involves a linkage intervention rather than medication, it does not directly list side effects like drug trials do. However, participants may experience stress or anxiety related to changes in their care routine.
Linkage Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am an adult who has completed 2 weeks at Kaiser's San Francisco addiction recovery program.
Linkage Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 and 24 months post baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 and 24 months post baseline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Substance use and mental health outcomes
patient activation measure
patient engagement in health care (including patient portal use, familiarity and satisfaction with Primary Care physician, and CD treatment length of stay)
Secondary outcome measures
Health care utilization and cost
Substance use and mental health outcomes at 12 and 24 months
patient activation measure at 12 and 24 months
+1 moreLinkage Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Linkage patient activation interventionExperimental Treatment1 Intervention
Usual Care with the exception that the six 45-min Linkage patient activation education groups replaced the six 45-min Usual Care medical education groups, plus a linkage phone call (and/or a facilitated email) with the patient, clinician, and Primary Care physician.
Group II: Usual CareActive Control1 Intervention
Usual CD treatment, including therapy groups and individual counseling sessions, and six 45-min medical education groups. Physician appointments, pharmacotherapy, and SUD medications were be available as needed.
Find a Location
Who is running the clinical trial?
Kaiser PermanenteLead Sponsor
538 Previous Clinical Trials
24,113,324 Total Patients Enrolled
Kaiser Foundation Research InstituteOTHER
27 Previous Clinical Trials
20,792 Total Patients Enrolled
Constance M Weisner, DrPH, LCSWPrincipal InvestigatorKaiser Permanente
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am an adult who has completed 2 weeks at Kaiser's San Francisco addiction recovery program.
Research Study Groups:
This trial has the following groups:- Group 1: Usual Care
- Group 2: Linkage patient activation intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What are the main targets of this investigation?
"This clinical trial has an evaluative period of 6 months post baseline, with the aim to assess Substance Use and Mental health outcomes. Secondary assessments encompass Healthcare Utilization & Cost, as well as Substance Use and Mental Health Outcomes at 12-24 month intervals; in addition to Patient Engagement in Healthcare over the same time frame. Research data for these analyses will be acquired from interviews, administrative records, PHQ-9 questionnaires and EHRs."
Answered by AI
Has recruitment for this experiment recently begun?
"According to information posted on clinicaltrials.gov, this investigation is not currently recruiting participants; it was first published in March 2011 and last modified on May 2nd 2022. Despite this trial's closure, 638 other medical trials are presently accepting candidates."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger